Value of endocrine therapy for early and locally advanced prostate cancer (Q35047981)

6 August 2017

1 reference

title

Value of endocrine therapy for early and locally advanced prostate cancer (English)

1 reference

6 August 2017

Manfred P Wirth

1

1 reference

6 August 2017

Michael Froehner

series ordinal

2

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

20

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

115-124

1 reference

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer

6 August 2017

cites work

1 reference

12 December 2020

The results of prostate carcinoma screening in the U.�S. As reflected in the surveillance, epidemiology, and end results program

1 reference

12 December 2020

Early results of radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation. The Prostate Cancer Study Group

1 reference

12 December 2020

A review of studies of hormonal adjuvant therapy in prostate cancer

1 reference

12 December 2020

A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer

1 reference

12 December 2020

Long-term outcome in patients with pTxN adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation

1 reference

12 December 2020

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

12 December 2020

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

12 December 2020

AN EVALUATION OF ENDOCRINE THERAPY PLUS RADICAL PERINEAL PROSTATECTOMY IN THE TREATMENT OF ADVANCED CARCINOMA OF THE PROSTATE

1 reference

12 December 2020

Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies

1 reference

12 December 2020

Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer.

1 reference

12 December 2020

Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer

1 reference

12 December 2020

Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated?

1 reference

12 December 2020

Delaying/reducing the risk of clinical tumour progression after primary curative procedures

1 reference

12 December 2020

Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors

1 reference

12 December 2020

Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis

1 reference

12 December 2020

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

12 December 2020

Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.

1 reference

12 December 2020

Adjuvant hormonal treatment with radiotherapy for locally advanced prostate cancer

1 reference

12 December 2020

Complete androgen blockade for prostate cancer: what went wrong?

1 reference

12 December 2020

Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy

1 reference

12 December 2020

Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

1 reference

12 December 2020

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

1 reference

12 December 2020

Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup

1 reference

12 December 2020

Hormonal treatment before radical prostatectomy: a 3-year followup

1 reference

12 December 2020

Androgen ablation in addition to radiation therapy for prostate cancer: Is there true benefit?

1 reference

12 December 2020

Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study

1 reference

12 December 2020

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

12 December 2020

Early androgen deprivation for prostate cancer?

1 reference

12 December 2020

Perspectives in adjuvant treatment of prostate cancer

1 reference

12 December 2020

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

12 December 2020

Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

1 reference

12 December 2020

Management of locally advanced prostate cancer. 2. Radiotherapy, neoadjuvant endocrine treatment, update 1997-1999.

1 reference

12 December 2020

Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis

1 reference

12 December 2020

Neoadjuvant androgen deprivation prior to transperineal prostate brachytherapy: smaller volumes, less morbidity

1 reference

12 December 2020

Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up

1 reference

12 December 2020

Osteoporosis due to androgen deprivation therapy in men with prostate cancer

1 reference

12 December 2020

Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer

1 reference

12 December 2020

Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy

1 reference

12 December 2020

State-of-the-art treatment of metastatic hormone-refractory prostate cancer

1 reference

12 December 2020

Hormone therapy for patients with prostate carcinoma

1 reference

12 December 2020

Radiotherapy with or without androgen deprivation in the treatment of localized adenocarcinoma of the prostate

1 reference

12 December 2020

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

1 reference

12 December 2020

Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer

1 reference

12 December 2020

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

12 December 2020

Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results

1 reference

12 December 2020

Adjuvant and neoadjuvant hormonal therapy for prostate cancer

1 reference

12 December 2020

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

12 December 2020

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

12 December 2020

The bicalutamide Early Prostate Cancer Program. Demography

1 reference

12 December 2020

10.2165/00002512-200320020-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

1013261324

0 references

1 reference